Evidence map›Paper›PMID 32451460›Full record

ArticleNature genetics2020

Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer.

Hae-Ock Lee, Yourae Hong, Hakki Emre Etlioglu, Yong Beom Cho, Valentina Pomella, Ben Van den Bosch, Jasper Vanhecke, Sara Verbandt, Hyekyung Hong, Jae-Woong Min and 27 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Nature genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 578 papers.

0numbers the graph read from it
0cells of the map it votes in
578citing papers in PubMed
40.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

578 citing papers in PubMed, 964 citations in OpenAlex.

  1. Dual metabolic checkpoint blockadeBioactive materials · 2027
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Multi-omics characterization of a GPRC5AJournal of translational medicine · 2026
    Article
  20. Article

518 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 11 institutions in 4 countries.

Hae-Ock Lee *Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.ORCID http://orcid.org/0000-0001-5123-0322
Yourae Hong *Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.ORCID http://orcid.org/0000-0001-6683-433X
Hakki Emre Etlioglu *Molecular Digestive Oncology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-4267-1307
Yong Beom Cho *Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea.
Valentina PomellaMolecular Digestive Oncology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
Ben Van den BoschMolecular Digestive Oncology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
Jasper VanheckeMolecular Digestive Oncology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
Sara VerbandtMolecular Digestive Oncology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
Hyekyung HongDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jae-Woong MinSamsung Genome Institute, Samsung Medical Center, Seoul, Korea.
Nayoung KimSamsung Genome Institute, Samsung Medical Center, Seoul, Korea.ORCID http://orcid.org/0000-0003-3202-750X
Hye Hyeon EumSamsung Genome Institute, Samsung Medical Center, Seoul, Korea.ORCID http://orcid.org/0000-0002-8081-4121
Junbin QianCenter for Cancer Biology, VIB, Leuven, Belgium.ORCID http://orcid.org/0000-0001-6145-045X
Bram BoeckxCenter for Cancer Biology, VIB, Leuven, Belgium.
Diether LambrechtsCenter for Cancer Biology, VIB, Leuven, Belgium.
Petros TsantoulisCentre d'Oncologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland.ORCID http://orcid.org/0000-0003-3613-6682
Gert De HertoghDepartment of Pathology, University Hospitals Leuven, Leuven, Belgium.
Woosung ChungSamsung Genome Institute, Samsung Medical Center, Seoul, Korea.
Taeseob LeeSamsung Genome Institute, Samsung Medical Center, Seoul, Korea.
Minae AnSamsung Genome Institute, Samsung Medical Center, Seoul, Korea.
Hyun-Tae ShinSamsung Genome Institute, Samsung Medical Center, Seoul, Korea.
Je-Gun JoungSamsung Genome Institute, Samsung Medical Center, Seoul, Korea.
Min-Hyeok JungDepartment of Biochemistry, College of Life Science and Technology, Yonsei University, Seoul, Korea.
Gunhwan KoKorean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea.
Pratyaksha WirapatiSwiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-0327-4686
Seok Hyung KimDepartment of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Hee Cheol KimDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Seong Hyeon YunDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Iain Bee Huat TanDivision of Medical Oncology, National Cancer Center, Singapore, Singapore.
Bobby RanjanSystems Biology and Data Analytics, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.ORCID http://orcid.org/0000-0001-5804-7205
Woo Yong LeeDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Tae-You KimCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Jung Kyoon ChoiDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea.
Young-Joon KimDepartment of Biochemistry, College of Life Science and Technology, Yonsei University, Seoul, Korea.
Shyam PrabhakarSystems Biology and Data Analytics, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.ORCID http://orcid.org/0000-0002-6409-0661
Sabine TejparMolecular Digestive Oncology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium. sabine.tejpar@uzleuven.be.ORCID http://orcid.org/0000-0003-3281-8643
Woong-Yang ParkSamsung Genome Institute, Samsung Medical Center, Seoul, Korea. woongyang.park@samsung.com.ORCID http://orcid.org/0000-0003-4234-0380
Samsung Medical Center · KRKU Leuven · BESamsung (South Korea) · KRAgency for Science, Technology and Research · SGVIB-KU Leuven Center for Cancer Biology · BEYonsei University · KRKorea Advanced Institute of Science and Technology · KRKorea Research Institute of Bioscience and Biotechnology · KRSeoul National University · KRSIB Swiss Institute of Bioinformatics · CHUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunotherapy for metastatic colorectal cancer is effective only for mismatch repair-deficient tumors with high microsatellite instability that demonstrate immune infiltration, suggesting that tumor cells can determine their immune microenvironment. To understand this cross-talk, we analyzed the transcriptome of 91,103 unsorted single cells from 23 Korean and 6 Belgian patients. Cancer cells displayed transcriptional features reminiscent of normal differentiation programs, and genetic alterations that apparently fostered immunosuppressive microenvironments directed by regulatory T cells, myofibroblasts and myeloid cells. Intercellular network reconstruction supported the association between cancer cell signatures and specific stromal or immune cell populations. Our collective view of the cellular landscape and intercellular interactions in colorectal cancer provide mechanistic information for the design of efficient immuno-oncology treatment strategies.

Indexed as

Cell LineageColorectal NeoplasmsGastric MucosaGene Expression Regulation, NeoplasticHumansSequence Analysis, RNASingle-Cell AnalysisStromal CellsT-LymphocytesTumor Microenvironment

Identifiers

PMID32451460
OpenAlexW3027774968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.